Advertisement

PARK2 presenting as a disabling peripheral axonal neuropathy

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig. 1

References

  1. 1.

    Khan NL, Graham E, Critchley P, Schrag AE, Wood NW, Lees AJ, Bhatia KP, Quinn N (2003) Parkin disease: a phenotypic study of a large case series. Brain 126:1279–1292

  2. 2.

    Abbruzzese G, Pigullo S, Schenone A, Bellone E, Marchese R, Di Maria E et al (2004) Does parkin play a role in the peripheral nervous system? A family report. Mov Disord 19:978–981

  3. 3.

    Okuma Y, Hattori N, Mizuno Y (2003) Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2). Parkinsonism Relat Disord 9(5):313–314

  4. 4.

    Ohsawa Y, Kurokawa K, Sonoo M, Yamada H, Hemmi S, Iwatsuki K et al (2005) Reduced amplitude of the sural nerve sensory action potential in PARK2 patients. Neurology 65:459–462

  5. 5.

    Kitada T, Asakawa S, Minoshima S, Mizuno Y, Shimizu N (2000) Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene. Mamm Genome 11:417–421

Download references

Acknowledgments

The authors would like to acknowledge the patient for his kind cooperation. This research received no specific grant from any funding agency.

Conflict of interest

The authors have no competing interests.

Author information

Correspondence to Joana Domingos.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Video: illustrates the steppage gait due to the peripheral neuropathy (the patient is on anti-parkinsonian therapy) (WMV 4547 kb)

Video: illustrates the steppage gait due to the peripheral neuropathy (the patient is on anti-parkinsonian therapy) (WMV 4547 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Domingos, J., Coelho, T., Taipa, R. et al. PARK2 presenting as a disabling peripheral axonal neuropathy. Neurol Sci 36, 341–343 (2015). https://doi.org/10.1007/s10072-014-1898-y

Download citation

Keywords

  • Nerve Conduction Study
  • Myelinated Fiber
  • Nerve Biopsy
  • Axonal Neuropathy
  • Motor Unit Action Potential